Research

Items by Bailey, Sarah

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 34.

Book Sections

Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.

Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers. Vol. 3. Netherlands: Springer, pp. 171-189.

Articles

Casal-Dominguez, J. J., Furkert, D., Ostovar, M., Teintang, L., Clarke, M. J., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2014. Characterization of BU09059:A novel potent selective κ-receptor antagonist. ACS Chemical Neuroscience, 5 (3), pp. 177-184.

Bailey, S., Casal-Dominguez, J. and Husbands, S. M., 2012. Antidepressant effects of novel kappa-opioid receptor antagonists in the forced swim test. Journal of Psychopharmacology, 26 (8), A16.

Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.

Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl,naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.

O'Reilly, K. C., Shumake, J., Bailey, S. J., Gonzalez-Lima, F. and Lane, M. A., 2009. Chronic 13-cis-retinoic acid administration disrupts network interactions between the raphe nuclei and the hippocampal system in young adult mice. European Journal of Pharmacology, 605 (1-3), pp. 68-77.

O'Reilly, K., Bailey, S. J. and Lane, M. A., 2008. Retinoid-mediated regulation of mood: Possible cellular mechanisms. Experimental Biology and Medicine, 233 (3), pp. 251-258.

O'Reilly, K. C., Bailey, S. J. and Lane, M. A., 2007. 13-Cis-retinoic acid alters serotonin reuptake transporter levels in RN46A-B14 raphe nuclei cells. FASEB Journal, 21 (6), A1178-A1178.

O'Reilly, K. C., Trent, S., Bailey, S. J. and Lane, M. A., 2007. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental Biology and Medicine, 232, pp. 1195-1203.

O'Reilly, K. C., Shumake, J., Gonzalez-Lima, F., Lane, M. A. and Bailey, S. J., 2006. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31 (9), pp. 1919-1927.

Slater, C. R., Fawcett, P. R. W., Walls, T. J., Lyons, P. R., Bailey, S. J., Beeson, D., Young, C. and Gardner-Medwin, D., 2006. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain, 129, pp. 2061-2076.

Lane, M. A. and Bailey, S. J., 2005. Role of retinoid signalling in the adult brain. Progress in Neurobiology, 75, pp. 275-293.

Wood, S. J. and Toth, M., 2001. Molecular pathways of anxiety revealed by knockout mice. Molecular Neurobiology, 23 (2-3), pp. 101-119.

Wood, S. and Slater, C. R., 2001. Safety factor at the neuromuscular junction. Progress in Neurobiology, 64 (4), pp. 393-429.

Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z. and Toth, M., 2001. The 5-HT1A receptor knockout mouse and anxiety. Behavioural Pharmacology, 12 (6-7), pp. 439-450.

This list was generated on Fri Aug 28 05:59:44 2015 IST.